Large international cohort study finds “insufficient evidence of excess harm” from this off-label use.
Takeaway
- Intravenous thrombolysis (IVT) did not appear to carry excess risk for symptomatic intracranial haemorrhage in patients with ischaemic stroke who had taken a direct oral anticoagulant (DOAC) in the past 48 hours.
Why this matters
- US and...
